These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2573769)

  • 1. Drug companies' evidence to justify advertising.
    Wade VA; Mansfield PR; McDonald PJ
    Lancet; 1989 Nov; 2(8674):1261-3. PubMed ID: 2573769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
    Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Written pharmaceutical advertising--still unreliable?].
    Gladsø KH; Garberg HR; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2014 Sep; 134(16):1563-8. PubMed ID: 25178232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of claims and references found in Australian pharmacy journal advertisements.
    Mandoh M; Curtain CM
    Int J Pharm Pract; 2017 Oct; 25(5):365-370. PubMed ID: 27896882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug marketing in the Third World.
    Hosking G
    Lancet; 1986 Jul; 2(8499):164. PubMed ID: 2873426
    [No Abstract]   [Full Text] [Related]  

  • 7. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
    Lexchin J
    CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
    Stewart KA; Neumann PJ
    Value Health; 2002; 5(5):390-7. PubMed ID: 12201856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drugging of the Third World.
    Silverman M; Lee PR; Lydecker M
    Int J Health Serv; 1982; 12(4):585-96. PubMed ID: 7141775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EU pledge for responsible marketing of food and beverages to children: implementation in food companies.
    Jensen JD; Ronit K
    Eur J Clin Nutr; 2015 Aug; 69(8):896-901. PubMed ID: 25828626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical advertising: from prospectus to marketing.
    Cambronero-Saiz B
    J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential role of postmarketing research.
    Venulet J
    Drugs Exp Clin Res; 1987; 13(11):673-83. PubMed ID: 3443043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal deception: the tobacco industry's "new" world standards for tobacco marketing].
    Saloojee Y; Hammond R
    Rev Panam Salud Publica; 2002 Feb; 11(2):119-27. PubMed ID: 11939114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of medicines.
    Massam D
    Lancet; 1989 Jun; 1(8650):1330. PubMed ID: 2566856
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug marketing in the Third World: beneath the cosmetic reforms.
    Greenhalgh T
    Lancet; 1986 Jun; 1(8493):1318-20. PubMed ID: 2872442
    [No Abstract]   [Full Text] [Related]  

  • 19. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug promotion and labeling in developing countries: an update.
    Lee PR; Lurie P; Silverman MM; Lydecker M
    J Clin Epidemiol; 1991; 44 Suppl 2():49S-55S. PubMed ID: 2045842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.